This occurs via activation of the STAT1/3-mediated regulation of IRF1 (interferon regulatory factor 1) in NSCLC, prostate cancer, and osteosarcoma [73,74,75]. The gene discussed is IRF1; the disease is non-small cell lung carcinoma.